SCHEMBL30075744

SCHEMBL30075744

CC(C)(C)OC(=O)N1CCC(=O)[C@](C)(F)C1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1H2 P55055 2/20 0.43
USP2 O75604 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
ESR2 Q92731 1/20 0.41
DDB1 Q16531 3/20 0.40
CRBN Q96SW2 3/20 0.40
CYP11B2 P19099 1/20 0.38
ADORA1 P30542 1/20 0.38
PDK4 Q16654 1/20 0.38
MAPT P10636 2/20 0.37
USP30 Q70CQ3 1/20 0.37
KDM4E B2RXH2 1/20 0.37
THRB P10828 1/20 0.37
ALDH1A1 P00352 1/20 0.37
LMNA P02545 1/20 0.37
RORC P51449 2/20 0.37
CTSD P07339 1/20 0.37
CTSE P14091 1/20 0.37
BACE1 P56817 1/20 0.37
HDAC2 Q92769 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15749495 1.00 NR1H2 (0.43) NR1H2USP2SMN1; SMN2ESR2DDB1
SCHEMBL518157 0.86 USP2 (0.42) NR1H2USP2SMN1; SMN2ESR2DDB1
Water SCHEMBL26621617 0.85 USP2 (0.41) NR1H2USP2SMN1; SMN2ESR2DDB1
SCHEMBL517374 0.84 NR1H2 (0.46) NR1H2USP2SMN1; SMN2ESR2DDB1
SCHEMBL20400529 0.82 GRM5 (0.40) NR1H2USP2SMN1; SMN2ESR2DDB1
Iodomethane SCHEMBL3387530 0.82 NR1H2 (0.44) NR1H2USP2SMN1; SMN2ESR2DDB1
SCHEMBL23578705 0.81 DDB1 (0.40) NR1H2USP2SMN1; SMN2ESR2DDB1
SCHEMBL23592779 0.81 DDB1 (0.40) NR1H2USP2SMN1; SMN2ESR2DDB1
SCHEMBL29201264 0.81 NR1H2 (0.40) NR1H2USP2SMN1; SMN2ESR2DDB1
SCHEMBL29207289 0.81 USP2 (0.41) NR1H2USP2SMN1; SMN2ESR2DDB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4081515-A1 INHIBITORS OF MUTANT FORMS OF EGFR Blueprint Medicines Corporation (US) 2022-11-02 EP disclosed